1 – 10 of 17
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Visual acuity outcomes up to 12 years and risk factors for visual impairment in a national cohort of extremely preterm born children – The Extremely Preterm Infants in Sweden Study (EXPRESS)
(2025) In Acta Ophthalmologica
- Contribution to journal › Article
-
Mark
Evaluation of timed dexamethasone eye drops to prevent proliferative retinopathy of prematurity : a study protocol for a randomized intervention, multi-centre, double-blinded trial (DROPROP)
- Contribution to journal › Article
- 2024
-
Mark
Treatment for retinopathy of prematurity in Sweden 2008–2021 : Reduced gestational age of treated infants and remaining differences in treatment type and recurrence rates between hospitals
- Contribution to journal › Article
- 2022
-
Mark
Dexamethasone eye-drops for treatment of retinopathy of prematurity
- Contribution to journal › Article
-
Mark
Mother's Own Milk and Its Relationship to Growth and Morbidity in a Population-based Cohort of Extremely Preterm Infants
- Contribution to journal › Article
-
Mark
Longitudinal Serum Metabolomics in Extremely Premature Infants : Relationships With Gestational Age, Nutrition, and Morbidities
- Contribution to journal › Article
- 2019
-
Mark
rhIGF-1/rhIGFBP-3 in Preterm Infants : A Phase 2 Randomized Controlled Trial
- Contribution to journal › Article
- 2018
-
Mark
Photoreceptor glucose metabolism determines normal retinal vascular growth
- Contribution to journal › Article
-
Mark
Increased frequency of retinopathy of prematurity over the last decade and significant regional differences
- Contribution to journal › Article
-
Mark
Extreme prematurity, treated retinopathy, bronchopulmonary dysplasia and cerebral palsy are significant risk factors for ophthalmological abnormalities at 6.5 years of age
- Contribution to journal › Article
